ArticleDigestive diseases and sciences2026
Outcomes of Risankizumab in Patients with Crohn's Disease and Prior Ustekinumab Exposure in a Multicenter Academic Institution.
Asrita Vattikonda et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it